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In this issue of Immunity, Stranges et al. (2007) ablate expression of the death receptor Fas in T cells,
B cells, and DC. Fas deficiency in any of these lineages is sufficient to break self-tolerance.Ever since the pivotal discoveries that
mutations in the tumor necrosis factor
(TNF)-family receptor Fas (also known
as CD95 or Apo-1) cause the recessive
autoimmue lpr syndrome in mice and
the autosomal dominant autoimmune
lymphoproliferative syndrome (ALPS)
in humans (Fisher et al., 1995;
Watanabe-Fukunaga et al., 1992),
understanding how Fas protects from
systemic autoimmunity has been the
subject of intense investigation. Al-
though Fas is well known to trigger
cell death in vitro in multiple cell types,
it has been less clear in which cells
Fas functions to protect from auto-
immunity in the intact immune system.
By using mouse lines in which Fas
expression is ablated in specific cell
types through Cre-lox-mediated gene
excision, Stranges et al. (2007) in this
issue of Immunity offer the startling
answer that autoimmunity can result
from the lineage-specific loss of Fas
in either T cells, B cells, or dendritic
cells (DCs). This study also reveals
interesting differences between the
consequences of Fas deletion in each
lineage.
Fas is inducibly expressed in multi-
ple lineages of immune cells, as well
as constitutively in other tissues, such
as hepatocytes, whereas expression
of its ligand, FasL, is more tightly con-
trolled. FasL appears transiently on T
cells only after stimulation though the
T cell receptor (TCR), and in vitro, it
can trigger apoptosis after TCR re-
stimulation of activated CD4+ T cells
(Figure 1; Siegel et al., 2000). Early ev-
idence from chimeric mice suggested
that collaboration between Fas-
deficient T and B cells is required for
maximal autoimmunity (Sobel et al.,
1994). Also, re-expression of Fas on
T cells in Fas-deficient mice reduces
autoantibody titers and loss of the‘‘double-negative’’ CD4CD8 T cell
population that characteristically
develops in mice or humans with
functional Fas or FasL deficiency.
Understanding the role of Fas in the
intact immune system became more
complex because of recent findings
that have suggested alternative func-
tions for Fas-FasL signaling. First,
caspases have been recognized to
have nonapoptotic cellular functions,
including involvement in the activation
of the NF-kB transcription factor. For
this reason, blockade of Fas signaling
downstream of the receptor through
genetic ablation or mutation of the
downstream signaling proteins FADDImmunor Caspase-8 does not reproduce the
phenotype of Fas deficiency, but in-
stead results in defective lymphocyte
development and activation (Siegel,
2006). Although interesting, these find-
ings prevented insights from being
gained about the consequences of tis-
sue-specific Fas deficiency. The first
group to employ Cre-lox-mediated tis-
sue-specific elimination of Fas found,
like Stranges et al. (2007), that Fas
deletion in B cells did result in auto-
antibody production and lymphocyte
expansion. However, T cell-specific
deletion of Fas resulted in lymphocyte
depletion and fatal fibrotic lungdisease
because of hyperexpression of FasLFigure 1. Fas-Dependent and -Independent Interactions that Lead to Immune Cell
Death
After initial expansion, many T cells die via a passive process of post-activation cell death, which
depends on the intrinsic cell-death pathways and molecules such as Bim, but not death receptors
such as Fas. Fas-FasL interactions are responsible for autocrine apoptosis of restimulated T cells
(restimulation cell death or RICD). FasL produced by recently activated T cells can induce apo-
ptosis in DCs through Fas. Fas on B cells also controls B cell numbers and prevents autoantibody
secretion. Deficiency of Fas in any one of these lineages as shown by Stranges et al. (2007) leads to
ANA production and accumulation of different cell types depending on which lineage is rendered
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Immunity
Previewson Fas-deficient T cells (Hao et al.,
2004). This syndrome, reminiscent of
the FasL-dependent graft-versus-
host disease-like syndrome that re-
sults when Fas-deficient cells are
transferred into irradiated hosts, also
prevented analysis of the role of Fas
in T cells in otherwise healthy mice.
In this context, the results of
Stranges et al. (2007) provide welcome
clarification of the role of Fas in various
immune cell lineages and re-empha-
size the role of Fas as an enforcer of
self-tolerance in multiple lineages of
immune cells. By using lineage-
specific expression of the Cre recom-
binase crossed to mice in which exon
9 of Fas was surrounded by loxP sites,
Stranges et al. (2007) analyzed the fate
of mice in which DCs, T cells, and B
cells havebeen rendered Fasdeficient.
Previous work had suggested that Fas
onDCscouldbe anegative regulator of
T cell responses, and labeled DCs
were found to have a short half-life in
vivo in the presence of antigen-specific
T cells. Whether or not these phenom-
ena were due to Fas-FasL interactions
was not known. From experiments
mixing Fas-deficient dendritic cells
and FasL-deficient antigen-specific T
cells, Stranges et al. (2007) now show
that FasL on T cells interacting with
Fas on DC is required for antigen-spe-
cific DC deletion. When Fas was elimi-
nated through Cre-mediated deletion,
there was also accumulation of acti-
vated DCs in the spleens of these
mice.More importantly, thesemicede-
veloped classical markers of systemic
autoimmunity including hypergamma-
globulinemia and elevated amounts of
antinuclear antibodies (ANAs) within
12–16 weeks of age. These results
correlate well and strengthen previous
observations of systemic autoimmu-
nity in mice with DCs expressing p35,
a baculovirus-derived caspase inhibi-
tor (Chen et al., 2006). Because p35 is
a blocker of multiple death receptors
aswell as intrinsicmechanisms of apo-
ptosis, the study by Stranges et al.
(2007) is important in confirming the
specific role of Fas in DC homeostasis
and controlling the immunogenicity of
self-antigen presentation.
B cells have a dual role in autoimmu-
nity both as the producers of auto-
antibodies and as antigen-presenting546 Immunity 26, May 2007 ª2007 Elsevcells for autoantigens, a function that
is likely enhanced in autoreactive B
cells because of more efficient presen-
tation of antigens via BCR-induced en-
docytosis. In the study by Stranges
et al. (2007), mice with B cell-specific
Fas deficiency developed marked
splenomegaly and lymphadenopathy,
as well as elevated ANA. Interestingly,
the cells expanded in these mice were
mainly T cells, suggesting that Fas on
B cells is somehow necessary for re-
straining the accumulation of Fas-
intact T cells. These results expand
on earlier findings in which B cells
were found to be required for the accu-
mulation of memory-phenotype T cells
in the setting of global Fas deficiency
(Chan and Shlomchik, 1998).
In case of T cell-specific Fas dele-
tion, the authors used Lck-Cre as well
as Gzmb (encoding granzyme B)-Cre
transgenic mice to target all T cells or
activated T cells, respectively. Surpris-
ingly, T cell-specific deletion of Fas did
not lead to lymphadenopathy or
splenomegaly, but these mice did pro-
duce ANAs. One feature of Fas defi-
ciency that was only reproduced in T
cell-specific Fas deficiency is the ac-
cumulation of CD4CD8B220+ dou-
ble-negative T (DN T) cells, a popula-
tion of cells that develop in lpr and
gld mice as well as in ALPS patients.
These cells appeared in both the
Lck-Cre as well asGzmb-Cre mice, in-
dicating that ‘‘double-negative’’ T cells
likely arise from previously activated T
cells and arise without the need for Fas
deficiency in other cell types. Other
groups have shown that Fas-deficient
mice appear to respond normally to
exogenously administered antigens.
Stranges et al. (2007) confirmed this
in the setting of T cell-specific Fas
deficiency by demonstrating that the
number of cytokine-producing anti-
gen-specific T cells was not elevated
at the peak of the primary T cell re-
sponse. However, the fact that T cell-
specific Fas deficiency also allowed
production of ANAs suggests, at least
indirectly, that Fas deficiency in T cells
alone is enough to break tolerance to
nuclear self-antigens.
This study may appear to conflict
with previous reports that restoring
Fas in one lineage of immune cells
corrects many aspects of the lpr syn-ier Inc.drome. Unfortunately, most of the find-
ings in tissue-selective Fas deficiency
were not directly compared with fully
Fas-deficient or lpr mice in this study.
However, the effects of Fas deficiency
in different cell types are likely to be ad-
ditive. True autoimmune disease itself
could not be tested because this study
was done with mice on the non-auto-
immune-prone C57BL/6 background,
in which Fas deficiency results in ANA
production but little autoimmune pa-
thology. The lack of FasL-mediated
lung pathology in the T cell-specific
Fas-deficient mice generated by
Stranges et al. (2007) in contrast to
those of Hao et al. (2004) is more puz-
zling, perhaps resulting from back-
ground straindifferences that influence
the amount of FasL hyperexpression.
The strikingconclusion that emerges
from these studies is that FasL-medi-
ated elimination of DCs and B cells
occurs after the presentation of both
acute exposure to a foreign antigen
as well as to self-antigens. However,
for T cells, Fas plays a role in eliminat-
ing only those cells with a TCR specific
for chronically expressed antigens in-
cluding autoantigens (Figure 1). These
findings mesh nicely with recently de-
scribed clinical observations of pa-
tients who have developed ALPS from
somatic dominant-negative Fas muta-
tions detected only in the T cell lineage
(Holzelova et al., 2004). Investigating
the complex crosstalk between differ-
ent immune cell lineages when Fas is
absent will undoubtedly result in more
fascinating findings about this receptor
that is so critical in self-tolerance.
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Transforming growth factor-b (TGF-b)
has long been recognized for its immu-
noregulatory functions in controlling
inflammation. Mice carrying a Tgfb1
null mutation suffer severe inflamma-
tory disease leading to early death;
this disease phenotype is partly asso-
ciated with the dependence of Foxp3+
regulatory T (Treg) cells on TGF-b
signaling for their maintenance in the
periphery. TGF-b production by Treg
cells has also been suggested as an
important (if controversial) mechanism
of suppression. Recently, TGF-b has
been in the spotlight because of its
emerging roles in the differentiation of
both inducible Foxp3+ Treg cells and
RORgt+ T helper 17 (Th17) cells from
naive T cells (Bettelli et al., 2006;
Ivanov et al., 2006), with interleukin-2
(IL-2) and IL-6 acting as switch factors
between Treg and Th17 cells, respec-
tively (Bettelli et al., 2006; Laurence
et al., 2007) (Figure 1). The potential
cellular sources of TGF-b in vivo are
many, and in the current issue of
Immunity, Li et al. (2007) have used
mice with a CD4+ T cell-specific dele-
tion of TGF-b1 to investigate the con-
tribution of T cell-produced TGF-b to
the maintenance of tolerance andSobel, E.S., Kakkanaiah, V.N., Kakkanaiah, M.,
Cheek, R.L., Cohen, P.L., and Eisenberg, R.A.
(1994). J. Immunol. 152, 6011–6016.
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development of autoreactive T cells
in vivo.
Li et al. (2007) find that mice with T
cell-specific deletion of TGF-b1 devel-
oped a similar wasting disease to
that observed in TGF-b1 complete-
knockout mice and T cell-restricted
TGF-bRII knockout mice: multiorgan
leukocyte infiltration, autoantibody
production, and early lethality. How-
ever, because the phenotype is less
severe and disease onset substantially
delayed, T cells are not the only source
of TGF-b that regulates peripheral
tolerance.
Unlike TGF-b1-deficient mice, the
numbers of peripheral Treg cells are
normal or increased in mice with a T
cell-specific deletion of TGF-b. The
inflammatory disease manifested in
these mice therefore could not be at-
tributed to a lack of Treg cells per se.
However, it was unclear whether the
disease regulation was mediated by
Foxp3+ Treg cells or naive Foxp3
T cells because both were observed
to produce TGF-b after T cell-receptor
ligation. Thus, the authors investigated
the relative contributions of Foxp3+
and Foxp3 cells in the T cell transfer
model of colitis, in which Treg-cell-
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mediated suppression of inflammation
is dependent on functional TGF-bRII
signaling in naive T cells. In this model,
Treg-cell production of paracrine TGF-
b was found to be crucial for control of
colitis, whereas naive T cells provide
a very minor contribution. Previous
studies had purified Treg cells on the
basis of CD25 expression—also a
marker of activated T cells—which
may have confounded the results.
The distinct advantage of the current
study was the purification of Treg cells
on the basis of Foxp3 expression, thus
eliminating contamination from acti-
vated T cells and clearly demonstrat-
ing an essential role for Treg cell
production of TGF-b.
One of the most striking findings of
this study is the clear dichotomy in
the generation of effector T helper sub-
sets: T cell-specific deletion of TGF-b
resulted in increased frequencies of
Th1 and Th2 cells but a decrease in
the frequency of Th17 cells. This re-
vealed two important points. First, the
multiorgan inflammatory disease and
colitis observed in these mice are pre-
dominantly mediated by Th1 cells and
do not require the generation of Th17
cells. Second, T cells themselves are
ty 26, May 2007 ª2007 Elsevier Inc. 547
